These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12714159)

  • 1. Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
    Lauten WB; Khan QA; Rajagopalan S; Lerakis S; Rahman ST; Parthasarathy S; Khan BV
    Am J Cardiol; 2003 May; 91(9):1116-9. PubMed ID: 12714159
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-6 (IL-6)-174 G/C polymorphism--lack of association with inflammatory and haemostatic variables in patients with coronary heart disease treated with atorvastatin and quinapril.
    Potaczek DP; Undas A; Szczeklik A
    Int J Cardiol; 2006 Sep; 112(1):123-4. PubMed ID: 16337287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some new data concerning effectiveness of amlodipine, atorvastatine and quinaprile for heart diseases].
    Ostroumova OD
    Kardiologiia; 2002; 42(3):99-104. PubMed ID: 12494197
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of quinapril and irbesartan on P-wave dispersion in hypertensive patients.
    Guntekin U; Gunes Y; Tuncer M; Simsek H; Gunes A
    Adv Ther; 2008 Aug; 25(8):775-86. PubMed ID: 18670740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan.
    Beer C; Blacker D; Bynevelt M; Hankey GJ; Puddey IB
    Int J Stroke; 2012 Feb; 7(2):104-11. PubMed ID: 22044557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction.
    Bank AJ; Kelly AS; Kaiser DR; Crawford WW; Waxman B; Schow DA; Billups KL
    Vasc Med; 2006 Nov; 11(4):251-7. PubMed ID: 17390549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical data: AVERT and QUO VADIS.
    O'Neill BJ
    Can J Cardiol; 2000 Aug; 16 Suppl E():32E-35E. PubMed ID: 10906624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy.
    Undas A; Brummel-Ziedins KE; Potaczek DP; Stobierska-Dzierzek B; Bryniarski L; Szczeklik A; Mann KG
    J Thromb Haemost; 2006 Nov; 4(11):2397-404. PubMed ID: 16907931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension.
    Ubaid-Girioli S; Ferreira-Melo SE; Souza LA; Nogueira EA; Yugar-Toledo JC; Coca A; Moreno H
    J Clin Hypertens (Greenwich); 2007 Oct; 9(10):770-4. PubMed ID: 17917504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
    Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical restenosis trials: a perspective from the pharmaceutical industry.
    Uprichard AC; Texter M; Canter D
    Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group.
    Tonkon M; Awan N; Niazi I; Hanley P; Baruch L; Wolf RA; Block AJ
    Int J Clin Pract; 2000; 54(1):11-4, 16-8. PubMed ID: 10750252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 19. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.